Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Abstract Background The ERBB2 oncogene hypothesis is challenged in hepatocellular carcinoma (HCC) with the conflicting evidences of human epidermal growth factor receptor 2 (HER2) overexpression. HER2 could be a new target as a treatment option for HCC as well as tumor recurrence after surgery. HER2...
Saved in:
Main Authors: | Ji‐Hua Shi, Wen‐Zhi Guo, Yang Jin, Hua-Peng Zhang, Chun Pang, Jie Li, Pål‐Dag Line, Shui‐Jun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the Progress of Musashi-2 in Malignant Tumors
by: Yiting Niu, et al.
Published: (2025-01-01) -
Endoplasmic reticulum stress-related CLIP4 plays a procarcinogenic role in hepatocellular carcinoma: an integrated analysis
by: Anqi Wang, et al.
Published: (2025-02-01) -
The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
by: Yu ZC, et al.
Published: (2025-01-01) -
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre
by: Anna-Maria Lazaratos, et al.
Published: (2024-12-01) -
Epithelial mesenchymal transition in human menstruation and implantation
by: Hiroshi Uchida
Published: (2024-08-01)